277 related articles for article (PubMed ID: 2895123)
21. Correlation between circulating levels of von Willebrand's antigen II and von Willebrand factor: discrimination between type I and type II von Willebrand's disease.
McCarroll DR; Ruggeri ZM; Montgomery RR
J Lab Clin Med; 1984 May; 103(5):704-11. PubMed ID: 6609219
[TBL] [Abstract][Full Text] [Related]
22. Understanding von Willebrand's disease from gene defects to the patients.
Zhang Z; Blombäck M; Anvret M
J Intern Med Suppl; 1997; 740():115-9. PubMed ID: 9350192
[TBL] [Abstract][Full Text] [Related]
23. Mutations in severe, type III von Willebrand's disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA.
Eikenboom JC; Ploos van Amstel HK; Reitsma PH; Briët E
Thromb Haemost; 1992 Oct; 68(4):448-54. PubMed ID: 1448779
[TBL] [Abstract][Full Text] [Related]
24. Plasma collagen cofactor correlates with von Willebrand factor antigen and ristocetin cofactor but not with bleeding time.
Aihara M; Kimura A; Chiba Y; Yoshida Y
Thromb Haemost; 1988 Jun; 59(3):485-90. PubMed ID: 3142084
[TBL] [Abstract][Full Text] [Related]
25. [Clinical and genetic analysis of a severe vWD pedigree].
Yu L; Wang H; Du L
Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):451-4. PubMed ID: 11189480
[TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of a novel mutation in von Willebrand factor causing type 2B von Willebrand's disease.
Facey DA; Favaloro EJ; Koutts J; Berndt MC; Hertzberg MS
Br J Haematol; 1999 May; 105(2):538-41. PubMed ID: 10233434
[TBL] [Abstract][Full Text] [Related]
27. von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia).
Penas N; Pérez-Rodríguez A; Torea JH; Lourés E; Noya MS; López-Fernández MF; Batlle J
Am J Hematol; 2005 Nov; 80(3):188-96. PubMed ID: 16247740
[TBL] [Abstract][Full Text] [Related]
28. Von Willebrand's disease: a novel mutation, P1824H and the incidence of R1205H defect among families with dominant quantitative von Willebrand factor deficiency.
Casaña P; Cabrera N; Haya S; Cid AR; Aznar JA
Haematologica; 2006 Aug; 91(8):1130-3. PubMed ID: 16870550
[TBL] [Abstract][Full Text] [Related]
29. Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling.
Nitu-Whalley IC; Riddell A; Lee CA; Pasi KJ; Owens D; Enayat MS; Perkins SJ; Jenkins PV
Thromb Haemost; 2000 Dec; 84(6):998-1004. PubMed ID: 11154147
[TBL] [Abstract][Full Text] [Related]
30. Characterisation of type 2N von Willebrand disease using phenotypic and molecular techniques.
Nesbitt IM; Goodeve AC; Guilliatt AM; Makris M; Preston FE; Peake IR
Thromb Haemost; 1996 Jun; 75(6):959-64. PubMed ID: 8822593
[TBL] [Abstract][Full Text] [Related]
31. Carrier detection in severe von Willebrand's disease.
Gupta PK; Kannan M; Saxena R
Ann Hematol; 2004 Oct; 83(10):625-7. PubMed ID: 15316757
[TBL] [Abstract][Full Text] [Related]
32. The molecular analysis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors' Organisation Haemophilia Genetics Laboratory Network.
Keeney S; Bowen D; Cumming A; Enayat S; Goodeve A; Hill M;
Haemophilia; 2008 Sep; 14(5):1099-111. PubMed ID: 18637846
[TBL] [Abstract][Full Text] [Related]
33. Measurement of von Willebrand factor-specific mRNA and release and storage of von Willebrand factor from endothelial cells of dogs with type-I von Willebrand's disease.
Meinkoth JH; Meyers KM
Am J Vet Res; 1995 Dec; 56(12):1577-85. PubMed ID: 8599517
[TBL] [Abstract][Full Text] [Related]
34. Laboratory diagnosis and molecular basis of mild von Willebrand disease type 1.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van Vliet HH
Acta Haematol; 2009; 121(2-3):85-97. PubMed ID: 19506353
[TBL] [Abstract][Full Text] [Related]
35. von Willebrand disease: a database of point mutations, insertions, and deletions. For the Consortium on von Willebrand Factor Mutations and Polymorphisms, and the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis.
Ginsburg D; Sadler JE
Thromb Haemost; 1993 Feb; 69(2):177-84. PubMed ID: 8456431
[TBL] [Abstract][Full Text] [Related]
36. [Molecular study of type 2 von Willebrand disease].
Habart D; Smejkal P; Matýsková M; Turek P; Hrachovinová I; Vorlová Z
Cas Lek Cesk; 2003; 142(6):373-6. PubMed ID: 12924038
[TBL] [Abstract][Full Text] [Related]
37. Mutations in von Willebrand factor multimerization domains are not a common cause of classical type 1 von Willebrand disease.
Keeney S; Cumming A; Hay C
Thromb Haemost; 1999 Nov; 82(5):1446-50. PubMed ID: 10595636
[TBL] [Abstract][Full Text] [Related]
38. Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; van de Velde A; van Vliet H
Clin Appl Thromb Hemost; 2006 Oct; 12(4):397-420. PubMed ID: 17000885
[TBL] [Abstract][Full Text] [Related]
39. Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor.
Hilbert L; Jenkins PV; Gaucher C; Meriane E; Collins PW; Pasi KJ; Mazurier C
Thromb Haemost; 2000 Aug; 84(2):188-94. PubMed ID: 10959688
[TBL] [Abstract][Full Text] [Related]
40. Comparative mapping of distal murine chromosome 11 and human 17q21.3 in a region containing a modifying locus for murine plasma von Willebrand factor level.
Mohlke KL; Purkayastha AA; Westrick RJ; Ginsburg D
Genomics; 1998 Nov; 54(1):19-30. PubMed ID: 9806826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
